The clinical effects of peramivir on influenza virus infections in infants (age; over 28 days old, under 4 years old): an open-label,non-randomized, multi-centre study.

Trial Profile

The clinical effects of peramivir on influenza virus infections in infants (age; over 28 days old, under 4 years old): an open-label,non-randomized, multi-centre study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Aug 2013

At a glance

  • Drugs Peramivir (Primary)
  • Indications Influenza A virus H1N1 subtype; Influenza A virus H3N2 subtype; Influenza B virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Aug 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 20 Jan 2013 Planned number of patients changed from 24 to 48 as reported by University Hospital Medical Information Network - Japan.
    • 20 Jan 2013 Status changed from completed to recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top